TANTUCCI, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 10.892
EU - Europa 4.844
AS - Asia 2.977
Continente sconosciuto - Info sul continente non disponibili 52
AF - Africa 32
OC - Oceania 15
SA - Sud America 12
Totale 18.824
Nazione #
US - Stati Uniti d'America 10.845
CN - Cina 2.092
UA - Ucraina 1.813
DE - Germania 713
IT - Italia 671
GB - Regno Unito 456
FI - Finlandia 354
IN - India 345
HK - Hong Kong 342
IE - Irlanda 338
PL - Polonia 152
FR - Francia 141
SE - Svezia 100
TR - Turchia 71
SG - Singapore 66
BE - Belgio 56
EU - Europa 52
CA - Canada 46
MU - Mauritius 31
VN - Vietnam 18
IR - Iran 16
AU - Australia 13
NL - Olanda 10
RU - Federazione Russa 8
BR - Brasile 7
GR - Grecia 7
MK - Macedonia 7
RO - Romania 5
JP - Giappone 4
LA - Repubblica Popolare Democratica del Laos 4
CY - Cipro 3
ID - Indonesia 3
SA - Arabia Saudita 3
AR - Argentina 2
DK - Danimarca 2
ES - Italia 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
TW - Taiwan 2
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
IM - Isola di Man 1
IS - Islanda 1
KR - Corea 1
KW - Kuwait 1
LV - Lettonia 1
MX - Messico 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
RS - Serbia 1
Totale 18.824
Città #
Jacksonville 1.326
Chandler 1.292
Fairfield 943
Ashburn 885
Woodbridge 882
Houston 831
Ann Arbor 706
Princeton 621
Nanjing 562
Cambridge 426
New York 415
Wilmington 399
Hong Kong 340
Seattle 339
Dublin 316
Helsinki 262
Nanchang 214
Beijing 203
Brescia 163
Warsaw 151
Shenyang 146
Des Moines 140
Hebei 139
Changsha 108
Jinan 101
Tianjin 90
San Diego 81
Verona 79
Jiaxing 78
Milan 70
Lancaster 62
Kocaeli 59
Kunming 57
Brussels 56
Dearborn 53
Shanghai 52
Hangzhou 51
Ningbo 45
Lanzhou 35
Zhengzhou 33
Haikou 32
San Mateo 32
Toronto 28
San Francisco 27
Taizhou 27
Pune 26
Augusta 25
Washington 23
Changchun 22
Norwalk 21
London 19
Trento 19
Taiyuan 18
Dong Ket 17
Guangzhou 17
Leawood 17
Auburn Hills 15
Fuzhou 15
Azzano 14
Boardman 14
Menlo Park 14
Ardabil 12
Mumbai 12
Rome 12
Gunzenhausen 9
Hefei 9
Cazzago San Martino 8
New Bedfont 8
Monmouth Junction 7
North York 7
Patras 7
Redwood City 7
Skopje 7
São Paulo 7
Westminster 7
Los Angeles 6
Orange 6
Palermo 6
Canosa Di Puglia 5
Frankfurt am Main 5
Hanover 5
Islington 5
Kilburn 5
Melbourne 5
Monza 5
Ottawa 5
San Giovanni Valdarno 5
Acton 4
Canberra 4
Hounslow 4
Mantova 4
Naples 4
Piangipane 4
Redmond 4
San Giovanni Lupatoto 4
Sydney 4
Tokyo 4
Trieste 4
Amsterdam 3
Gorla Maggiore 3
Totale 13.485
Nome #
Bone ultrasonometric features and grow hormone secretion in asthmatic patients during chronic inhaled corticosteroid therapy 142
Effetti cardiovascolari della ventilazione servo-adattativa (ASV) in pazienti affetti da apnee notturne e scompenso cardiaco cronico con disfunzione sistolica ventricolare sinistra 141
Central airways remodeling in COPD patients 140
Increased QT dispersion : a negative prognostic finding in chronic obstructive pulmonary disease 137
Control of breathing and bronchial reactivity in diabetics with autonomic neuropathy. 127
Effects of CPAP on systemic hypertension in OSAH: a monocentric, observational, cohort study 126
Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease. 117
Methods for Measuring Lung Volumes: Is There a Better One? 116
Exercise tolerance in obstructive sleep apnea-hypopnea (OSAH), before and after CPAP treatment: Effects of autonomic dysfunction improvement 114
Acute dynamic hyperinflation and systemic inflammation in stable COPD patients. 109
Vitamin D and health status in elderly. 109
Buprenorphine vs. morphine via the epidural route: a controlled comparative clinical study of respiratory effects and analgesic activity. 108
Clinical consequences of airflow limitation. 108
AIRWAY DISTENSIBILITY AND VOLUME RECRUITMENT WITH LUNG INFLATION IN COPD. 107
Expiratory flow limitation and orthopnea in massively obese subjects. 106
Aging and the respiratory system. 105
Tidal airway closure during bronchoconstriction in asthma: usefulness of lung volume measurements. 105
Lung function decline in COPD 105
Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions 102
Cardiac Sympathetic Hyperactivity in Patients with Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea 102
Metabolic and hormonal effects of preferential beta 1 and beta 2-adrenoceptor stimulation in man. 101
Usefulness of Exhaled Nitric Oxide and Sputum Eosinophils in the long-term control of Eosinophilic Asthma 101
Long-term physical training leads to airway remodelling in animal model. 99
Expiratory flow limitation and orthopnea in massively obese subjects. 98
Introduction with special reference to ventilator-associated barotrauma. 97
The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency. 97
Il polmone da shock. 96
Sleep Apnea Syndrome in Endocrine Diseases 95
Evaluating the Emergency Department admission and hospitalization trend for COPD Exacerbation and time-dependent Particulate Matter exposure 95
Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients. 94
COPD and osteoporosis: something more than a comorbidity. 94
The best peak expiratory flow is flow-limited and effort independent in normal subjects. 93
Cerebrovascular reactivity and hypercapnic respiratory drive in diabetic autonomic neuropathy. 93
Inspiratory drive is related to dynamic pulmonary hyperinflation in COPD patients 93
The role of alpha-1-antitrypsin (AAT) Z polymers in the lung of patients with alpha-1-antitrypsin deficiency (AATD). 92
Skin prick-test reactivity to aeroallergens and allergic symptoms in an urban population of central Italy: a longitudinal study. 91
Upper airway dynamics during negative expiratory pressure in apneic and non-apneic awake snorers. 90
Alpha1-antitrypsin deficiency: a twenty-five years' experience. 90
Diagnostic flow chart for targeted detection of alpha-1-antitrypsin deficiency 89
Diagnostic flow chart for targered detection of Alpha-1-antitrypsin deficiency. 88
Cerebrovascular reactivity and hypercapnic respiratory drive in diabetic autonomic neuropathy. 87
Growth hormone response to growth hormone-releasing hormone is reduced in adult asthmatic patients receiving long-term inhaled corticosteroid treatment. 87
Expiratory flow limitation as a determinant of orthopnea in acute left heart failure. 86
Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest. 86
The best peak expiratory flow is flow-limited and effort independent in normal subjects. 86
Alterazioni della meccanica respiratoria. Limitazione dei flussi. 85
Expiratory flow limitation is associated with orthopnea and reversed by vasodilators and diuretics in left heart failure. 85
Respiratory function in patients with stable anorexia nervosa 85
Dynamic hyperinflation and flow limitation during methacholine-induced bronchoconstriction in asthma 84
Insufficienza respiratoria. 84
Predictors of nocturnal oxyhemoglobin desaturation in COPD. 84
Dose-Response curve to salbutamol during acute and chronic treatment with formoterol in COPD. 84
Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions 83
L'anziano di fronte ai problemi chirurgici: i fattori respiratori. 82
Sleep disordered breathing in nonobese diabetic subjects with autonomic neuropathy. 80
Pneumopatie interstiziali diffuse. 79
Autonomic neuropathy increases the risk of obstructive sleep apnea in obese diabetics. 79
Tidal airway closure in asthma and COPD 78
Alpha1-antitrypsin deficiency. The Brescia (Italy) clinical study [Il deficit di alfa1-antitripsina: Lo studio clinico di Brescia] 76
Daytime approach to Obstructive Sleep Apnea phenotyping 76
Bronchodilatators. 75
Relationship between critical pressure and volume exhaled during negative pressure in awake subjects with sleep-disordered breathing. 75
An-improved metabolic calibrator for stress equipment: protocol for its clinical utilization. 74
Ossigenoterapia. 74
Inspiratory capacity predicts mortality in COPD better than FEV1 74
Broncopneumopatia cronica ostruttiva. Le manifestazioni sistemiche. 73
ECSC PROJECT. Universities of Brescia and Ancona. 73
ASPETTI CARDIOVASCOLARI E RESPIRATORI NELLA NEUROPATIA AUTONOMICA DIABETICA 72
Respiratory mechanics in intensive care units. 72
Diagnostic flow chart for targeted detection of Alpha1-antitrypsin deficiency. 72
Dynamic pulmonary hyperinflation occurs without expiratory flow limitation in chronic heart failure during exercise 72
Airway hyperresponsiveness in a large group of subjects with alfa1-antitrypsin deficiency: a cross-sectional controlled study. 71
Ventilatory effects of selective Beta 1 (prenalterol) or Beta 2 (Salbutamol) adrenoceptor agonism in man. 71
Diversa risposta cardiovascolare e ormonale all'attività fisica massimale nei pazienti affetti da neuropatia autonomica con o senza ipotensione posturale. 70
Ineffectivenness of intravenous beta-2 agonist on improving exercise tolerance in patients with reversible chronic airway obsctruction. 70
Flow limitation: an overview. 70
Dynamic pulmonary hyperinflation and low grade systemic inflammaton in stable COPD patients. 70
Acute respiratory effects of sublingual buprenorphine: comparison with intramuscolar morphine. 69
Ineffectiveness of a four week treatment with the thromboxane synthetase inhibitor, inidazole salycilate, in reducing airway hyper-responsiveness to methacholine in asthmatics. 69
La nitrendipina, un nuovo calcioantagonista per il trattamento della ipertensione arteriosa. 68
L'anziano di fronte ai problemi chirurgici: " I fattori di rischio" respiratori. 68
Alterazioni funzionali respiratorie in corso di emodialisi: confronto fra dializzatori con membrane di cuprophan e poliacrilonitrite-AN69. 67
Epidemiologia delle pneumopatie croniche. 67
Pneumologia. 67
Aspetti cardiovascolari e respiratori della neuropatia autonomica diabetica. 67
Controllo del respiro nelle malattie neurologiche ed in particolare nella sclerosi multipla. 67
Analisi computerizzata della funzione respiratoria. 66
Round table on antiasthamatic drugs; beta-agonists and theophylline. Workshop on pathogenesis and therapy of bronchial asthma. 66
Metabolic and hormonal effects of preferential beta-1 and beta-2-adronoceptor stimulation in man. 66
Infuence of upper airway size on volume exhaled under negative pressure during evaluation of upper airway collapsibility 66
Alpha1-antitrypsin deficiency and abdominal aortic aneurysms: does this association really exist? 66
Effect of negative expiratory pressure (NEP) on respiratory system flow resistance in awake snorers and non-snorers. 65
Valutazione dell'equilibrio acido-base (Parte 1) 65
Acute effects of oral metoprolol on ventilatory function in patients with chronic obstructive lung disease. 65
Airway obstruction or closure during bronchoconstricction in asthma: can we preconize it? 65
Predictors of exercise-induced airways obstruction in patients with mild asthma 65
Broncodilatatori nell'asma bronchiale. 64
Scambi gassosi. 64
Spirometric preditions of exercise limitation in patients with COPD. 64
Respiratory prognosis in chest wall disease. 64
Totale 8.616
Categoria #
all - tutte 85.028
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.028


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019540 0 0 0 0 0 0 0 0 0 105 225 210
2019/20204.107 851 81 78 424 121 454 415 416 129 720 125 293
2020/20213.463 81 325 75 366 180 451 112 402 563 299 511 98
2021/20222.363 71 390 56 264 45 102 64 223 152 212 238 546
2022/20233.062 373 118 66 359 258 736 12 387 486 17 102 148
2023/20241.801 176 51 138 258 95 550 65 95 373 0 0 0
Totale 19.326